D C Shugars

1.8k total citations · 1 hit paper
13 papers, 1.5k citations indexed

About

D C Shugars is a scholar working on Virology, Public Health, Environmental and Occupational Health and Infectious Diseases. According to data from OpenAlex, D C Shugars has authored 13 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Virology, 5 papers in Public Health, Environmental and Occupational Health and 4 papers in Infectious Diseases. Recurrent topics in D C Shugars's work include HIV Research and Treatment (10 papers), HIV/AIDS oral health manifestations (5 papers) and Herpesvirus Infections and Treatments (3 papers). D C Shugars is often cited by papers focused on HIV Research and Treatment (10 papers), HIV/AIDS oral health manifestations (5 papers) and Herpesvirus Infections and Treatments (3 papers). D C Shugars collaborates with scholars based in United States. D C Shugars's co-authors include Carl Wild, Thomas J. Matthews, Charlene McDanal, Ronald Swanstrom, Pascale V. Nantermet, Monica Smith, Françoise Seillier‐Moiseiwitsch, J. Victor Garcia, Stephen J. Anderson and Lauren L. Patton and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Virology and Journal of Dental Research.

In The Last Decade

D C Shugars

13 papers receiving 1.5k citations

Hit Papers

Peptides corresponding to a predictive alpha-helical doma... 1994 2026 2004 2015 1994 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection.
    1994 804 citations Carl Wild, D C Shugars et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D C Shugars United States 12 1.1k 706 401 376 365 13 1.5k
Diane C. Shugars United States 17 785 0.7× 663 0.9× 225 0.6× 165 0.4× 309 0.8× 21 1.4k
Susan Engelbrecht South Africa 24 1.1k 1.0× 808 1.1× 241 0.6× 388 1.0× 439 1.2× 98 1.7k
Catarina E. Hioe United States 27 1.1k 1.0× 479 0.7× 1.1k 2.8× 532 1.4× 416 1.1× 82 1.9k
J M Orenstein United States 15 370 0.3× 278 0.4× 359 0.9× 193 0.5× 331 0.9× 18 1.3k
Mary Fran McLane United States 19 1.0k 1.0× 616 0.9× 641 1.6× 208 0.6× 294 0.8× 29 1.5k
Eleonora Tresoldi Italy 18 938 0.9× 461 0.7× 1.2k 3.0× 261 0.7× 281 0.8× 27 2.0k
Ludwig Deml Germany 23 488 0.5× 268 0.4× 765 1.9× 523 1.4× 431 1.2× 53 1.5k
Kathy Medvik United States 12 944 0.9× 574 0.8× 620 1.5× 177 0.5× 427 1.2× 17 1.5k
Graz Luzzi United Kingdom 21 1.2k 1.2× 456 0.6× 1.2k 2.9× 263 0.7× 470 1.3× 45 2.2k
F Gotch United Kingdom 26 870 0.8× 444 0.6× 1.7k 4.3× 475 1.3× 844 2.3× 64 2.6k

Countries citing papers authored by D C Shugars

Since Specialization
Citations

This map shows the geographic impact of D C Shugars's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D C Shugars with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D C Shugars more than expected).

Fields of papers citing papers by D C Shugars

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D C Shugars. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D C Shugars. The network helps show where D C Shugars may publish in the future.

Co-authorship network of co-authors of D C Shugars

This figure shows the co-authorship network connecting the top 25 collaborators of D C Shugars. A scholar is included among the top collaborators of D C Shugars based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D C Shugars. D C Shugars is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Divaris, Kimon, et al.. (2012). Risk Factors for Third Molar Occlusal Caries: A Longitudinal Clinical Investigation. Journal of Oral and Maxillofacial Surgery. 70(9). e38–e38. 1 indexed citations
2.
3.
Shugars, D C, et al.. (2001). Salivary Concentration of Secretory Leukocyte Protease Inhibitor, an Antimicrobial Protein, Is Decreased with Advanced Age. Gerontology. 47(5). 246–253. 44 indexed citations
4.
Shugars, D C, Lauren L. Patton, Stephanie A. Freel, et al.. (2001). Hyper-excretion of Human Immunodeficiency Virus Type 1 RNA in Saliva. Journal of Dental Research. 80(2). 414–420. 27 indexed citations
5.
Shugars, D C, et al.. (1999). Endogenous salivary inhibitors of Human Immunodeficiency Virus. Archives of Oral Biology. 44(6). 445–453. 41 indexed citations
6.
Patton, Lauren L. & D C Shugars. (1999). IMMUNOLOGIC AND VIRAL MARKERS OF HIV-1 DISEASE PROGRESSION: IMPLICATIONS FOR DENTISTRY. The Journal of the American Dental Association. 130(9). 1313–1322. 20 indexed citations
7.
8.
Shugars, D C, et al.. (1997). Secretory leukocyte protease inhibitor (SLPI) in mucosal fluids inhibits HIV‐1. Oral Diseases. 3(S1). S64–9. 136 indexed citations
9.
Shugars, D C & Lauren L. Patton. (1997). Detecting, diagnosing, and preventing oral cancer.. PubMed. 22(6). 105, 109–10, 113. 21 indexed citations
10.
11.
Wild, Carl, et al.. (1994). Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection.. Proceedings of the National Academy of Sciences. 91(21). 9770–9774. 804 indexed citations breakdown →
12.
Shugars, D C, et al.. (1993). Analysis of human immunodeficiency virus type 1 nef gene sequences present in vivo. Journal of Virology. 67(8). 4639–4650. 212 indexed citations
13.
Anderson, Stephen J., D C Shugars, Ronald Swanstrom, & J. Victor Garcia. (1993). Nef from primary isolates of human immunodeficiency virus type 1 suppresses surface CD4 expression in human and mouse T cells. Journal of Virology. 67(8). 4923–4931. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Diane C. Shugars Breakdown of academic impact, for papers by Susan Engelbrecht Breakdown of academic impact, for papers by Catarina E. Hioe Breakdown of academic impact, for papers by J M Orenstein Breakdown of academic impact, for papers by Mary Fran McLane Breakdown of academic impact, for papers by Eleonora Tresoldi Breakdown of academic impact, for papers by Ludwig Deml Breakdown of academic impact, for papers by Kathy Medvik Breakdown of academic impact, for papers by Graz Luzzi Breakdown of academic impact, for papers by F Gotch
Rankless by CCL
2026